Seprify, a biomaterials company headquartered in Fribourg, Switzerland, has secured €13.4 million (CHF 12.25 million) in Series A funding to scale production of its cellulose-based ingredients for industrial applications.
Seprify, a biomaterials company headquartered in Fribourg, Switzerland, has secured €13.4 million (CHF 12.25 million) in Series A funding to scale production of its cellulose-based ingredients for industrial applications.
AgentMail, a San Francisco startup developing communication infrastructure for autonomous AI agents, has secured $6 million in seed funding to expand its agent-native email platform.
Nitra, a company developing an AI-powered operating platform for healthcare practices, has secured $187 million in new financing through a combination of Series A and Series B equity funding, venture debt, and a warehouse facility.
Escape, an offensive security engineering platform founded in Paris, has raised €15.4 million ($18 million) in a Series A funding round to expand its AI-powered cybersecurity platform.
AMI Labs, a new artificial intelligence research company co-founded by Turing Award winner Yann LeCun, has raised $1.03 billion in funding at a $3.5 billion pre-money valuation.
Staircase Ventures, an early-stage venture capital firm headquartered in Toronto, has closed its second fund at $50 million CAD, surpassing its original target of $40 million.
Cytotrait, a biotechnology startup spun out of the University of Manchester, has secured £3 million in seed funding to advance its gene-editing platform designed for agricultural applications.
Qevlar AI, a cybersecurity startup headquartered in Paris, has raised €25.8 million ($30 million) in new funding to further develop its AI-powered Security Operations Centre (SOC) platform.
Isembard, a London-based precision manufacturing company, has raised €43 million ($50 million) in a Series A funding round to expand its network of software-driven factories and scale operations across Europe.
